The landscape of blood sugar treatment is advancing with the introduction of skin-applied GLP-1 therapy. These novel patches offer a potentially less invasive alternative to injections for individuals dealing with diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the skin ,